Cargando…
Rethinking treatment for RET-altered lung and thyroid cancers: selpercatinib approval by the EMA
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820024/ https://www.ncbi.nlm.nih.gov/pubmed/33477006 http://dx.doi.org/10.1016/j.esmoop.2020.100041 |
| _version_ | 1783639123258507264 |
|---|---|
| author | Della Corte, C.M. Morgillo, F. |
| author_facet | Della Corte, C.M. Morgillo, F. |
| author_sort | Della Corte, C.M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7820024 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78200242021-01-29 Rethinking treatment for RET-altered lung and thyroid cancers: selpercatinib approval by the EMA Della Corte, C.M. Morgillo, F. ESMO Open Editorial Elsevier 2021-01-18 /pmc/articles/PMC7820024/ /pubmed/33477006 http://dx.doi.org/10.1016/j.esmoop.2020.100041 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Editorial Della Corte, C.M. Morgillo, F. Rethinking treatment for RET-altered lung and thyroid cancers: selpercatinib approval by the EMA |
| title | Rethinking treatment for RET-altered lung and thyroid cancers: selpercatinib approval by the EMA |
| title_full | Rethinking treatment for RET-altered lung and thyroid cancers: selpercatinib approval by the EMA |
| title_fullStr | Rethinking treatment for RET-altered lung and thyroid cancers: selpercatinib approval by the EMA |
| title_full_unstemmed | Rethinking treatment for RET-altered lung and thyroid cancers: selpercatinib approval by the EMA |
| title_short | Rethinking treatment for RET-altered lung and thyroid cancers: selpercatinib approval by the EMA |
| title_sort | rethinking treatment for ret-altered lung and thyroid cancers: selpercatinib approval by the ema |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820024/ https://www.ncbi.nlm.nih.gov/pubmed/33477006 http://dx.doi.org/10.1016/j.esmoop.2020.100041 |
| work_keys_str_mv | AT dellacortecm rethinkingtreatmentforretalteredlungandthyroidcancersselpercatinibapprovalbytheema AT morgillof rethinkingtreatmentforretalteredlungandthyroidcancersselpercatinibapprovalbytheema |